Skip to main content

Table 1 Clinical characteristics of the patients infected with mild-to-moderate SARS-CoV-2

From: Clinical and CT features of mild-to-moderate COVID-19 cases after two sequential negative nucleic acid testing results: a retrospective analysis

Variables

Total (n = 51)

Moderate (n = 31)

Mild (n = 20)

P

Ever went to Hubei (n,%)

   

0.539

 Yes

36 (70.6)

23 (74.2)

13 (65.0)

 

 No

15 (29.4)

8 (25.8)

7 (35.0)

 

Age, years

34.0 (20.0, 44.0)

37.0 (25.0, 48.0)

31.0 (16.0, 37.5)

0.288

Gender (n,%)

   

0.813

 Male

24 (47.1)

15 (48.4)

9 (45.0)

 

 Female

27 (52.9)

16 (51.6)

11 (55.0)

 

Incubation time, days

7.5 (1.0, 11.75)

8.0 (1.75, 12.0)

6.5 (0.0, 9.0)

0.361

Time to negative nucleic acid testing, days

3 (2, 7)

2 (4, 8)

2.5 (1.25, 5.5)

0.291

Symptoms at admission

 Fever (n,%)

34 (66.7)

23 (74.2)

11 (55.0)

0.156

 Duration of fever, days

5.0 (2.0, 7.0)

5.0 (2.0, 7.5)

4.0 (2.0, 6.0)

0.772

 Cough (n,%)

31 (60.8)

22 (71.0)

9 (45.0)

0.083

 Expectoration (n,%)

6 (11.8)

4 (12.9)

2 (10.0)

1.000

 Sore throat (n,%)

6 (11.8)

3 (9.7)

3 (15.0)

0.668

 Headache (n,%)

4 (7.8)

1 (3.2)

3 (15.0)

0.287

 Fatigue (n,%)

2 (3.9)

2 (6.5)

0 (0.0)

0.514

 Stuffy and runny nose (n,%)

4 (7.8)

1 (3.2)

3 (15.0)

0.287

 Gastrointestinal reaction (n,%)

5 (9.8)

4 (12.9)

1 (5.0)

0.636

 Chest tightness and dyspnea (n,%)

7 (13.7)

5 (16.1)

2 (10.0)

0.690

Symptoms after two sequential negative nucleic acid testing

 Fever (n,%)

0 (0)

0 (0)

0 (0)

 Cough (n,%)

17 (33.3)

11 (35.5)

6 (30.0)

0.767

 Expectoration (n,%)

7 (13.7)

5 (16.1)

2 (10.0)

0.690

 Sore throat (n,%)

4 (7.8)

3 (9.7)

1 (5.0)

1.000

 Headache (n,%)

2 (3.9)

0 (0.0)

2 (10.0)

0.149

 Fatigue (n,%)

3 (5.9)

1 (3.2)

2 (10.0)

0.553

 Stuffy and runny nose (n,%)

3 (5.9)

0 (0.0)

3 (15.0)

0.055

 Gastrointestinal reaction (n,%)

3 (5.9)

2 (6.5)

1 (5.0)

1.000

 Chest tightness and dyspnea (n,%)

3 (5.9)

1 (3.2)

2 (10.0)

0.553

 Pulse oximeter O2 saturation, %

97.3 ± 0.95

97.1 ± 0.89

97.6 ± 1.00

0.469

 Heart rate, breaths/min

86.7 ± 15.5

85.9 ± 15.7

88.0 ± 15.5

0.938

Disease history

 Bronchial or pulmonary disease (n,%)

4 (7.8)

4 (12.9)

0 (0.0)

0.094

 Other diseases (n,%)a

6 (11.8)

6 (19.6)

0 (0.0)

0.036

Treatment (n,%)b

0.216

 Western medicine

17 (34.7)

11 (35.5)

6 (33.3)

 

 Chinese medicine

15 (30.6)

7 (22.6)

8 (44.4)

 

 Both

17 (34.8)

13 (41.9)

4 (22.2)

 
  1. Chinese medicine: Jin Hua Qing Gan particles, antiviral particles, Xiang Sha Liu Jun pills, etc.
  2. aOther underlying diseases include glioma, nephrectomy, hyperlipidemia, gastric tumours, type 2 diabetes and thyroid cancer, etc.
  3. bWestern medicine: levofloxacin, moxifloxacin, ribavirin, abidol, lopinavir, ritonavir, interferon, thymoxin, chloroquine phosphate, interferon, oseltamivir, etc.